Antineoplastic AgentsNeoplasmsCell Line, TumorRadiation DosageRadiation, IonizingRadiation InjuriesDose-Response Relationship, RadiationRadiation ToleranceDrug Screening Assays, AntitumorRadiationTumor BurdenNeoplasms, ExperimentalTumor Markers, BiologicalDoxorubicinRadiation ProtectionXenograft Model Antitumor AssaysRadiation MonitoringApoptosisCell SurvivalMice, NudeTumor Necrosis Factor-alphaCell ProliferationDose-Response Relationship, DrugAntineoplastic Agents, PhytogenicCisplatinDrug Resistance, NeoplasmTumor Suppressor Protein p53Drug Delivery SystemsAntibiotics, AntineoplasticBrain NeoplasmsNeovascularization, PathologicTransplantation, HeterologousTumor Cells, CulturedCombined Modality TherapyWilms TumorAdenocarcinomaBreast NeoplasmsTime FactorsDrug CarriersNeoplasm TransplantationColonic NeoplasmsTreatment OutcomeRadiation OncologyMaximum Tolerated DoseNeoplasm MetastasisAntineoplastic Combined Chemotherapy ProtocolsPaclitaxelRadiation-Sensitizing AgentsMice, Inbred BALB CCell DivisionNeoplasms, Radiation-InducedGene Expression Regulation, NeoplasticCamptothecinTumor MicroenvironmentGamma RaysTumor Suppressor ProteinsNeoplasm ProteinsMammary Neoplasms, ExperimentalGenes, Tumor SuppressorDNA DamageRadiotherapySignal TransductionOvarian NeoplasmsAngiogenesis InhibitorsMice, SCIDCell CycleDrug SynergismEtoposideRadiation Injuries, ExperimentalCosmic RadiationDrug Administration ScheduleCarcinoid TumorAntibodies, MonoclonalProdrugsFibrosarcomaLung NeoplasmsLiver NeoplasmsAntigens, NeoplasmRNA, MessengerDNA, NeoplasmCarcinoma, Squamous CellGliomaNeuroendocrine TumorsMice, Inbred C57BLRadiation PneumonitisRadiotherapy DosageCell LineFlow CytometryInhibitory Concentration 50FluorouracilBlotting, WesternPancreatic NeoplasmsKidney NeoplasmsRadiometryEnzyme InhibitorsNeoplasm StagingCell HypoxiaMelanoma, ExperimentalUltraviolet RaysSarcoma, Experimental